Lincoln National Corp
LNC NYSE Life Insurance Financials FY2016βFY2025
What Lincoln National Corp does
No business description yet.
- Legal name
- LINCOLN NATIONAL CORP
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 19, 2026
- Accession Β· CIK
- 0000059558-26-000016
0000059558
Revenue and margins
Lincoln National Corp had $18.2B of revenue in fiscal 2025, down 1.2% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 1.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Lincoln National Corp returned $325M to shareholders in fiscal 2025. The diluted share count rose 7.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Lincoln National Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.6B | $3.3B | $3.4B | $5.8B | $9.5B |
| Debt incl. finance leases | $6.8B | $6.9B | $6.0B | $6.2B | $6.3B |
| Debt / equity | 0.3x | 1.3x | 0.9x | 0.7x | 0.6x |
| Total assets | $386.9B | $334.3B | $372.4B | $390.8B | $417.2B |
| Total liabilities | $366.2B | $329.2B | $365.5B | $382.6B | $406.3B |
| Shareholders' equity | $19.9B | $5.1B | $6.9B | $8.3B | $10.9B |
| Net debt (β = net cash) | $4.2B | $3.6B | $2.6B | $355M | β$3.2B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 7 | 6 / 7 | 2 / 7 | 5 / 7 | 4 / 7 | 5 / 7 | 2 / 7 | 4 / 7 | 2 / 7 |
| Accruals ratio | β0.0% | 0.5% | β0.1% | 1.1% | β0.0% | 1.1% | β0.6% | 0.4% | 1.4% | 0.3% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $13.3B | $14.3B | $16.4B | $17.3B | $17.4B | $17.7B | $18.8B | $11.6B | $18.4B | $18.2B |
| Interest expense | $331M | $253M | $297M | $326M | $284M | $270M | $283M | $331M | $336M | $227M |
| Pretax income | $1.5B | $1.1B | $1.9B | $919M | $423M | $4.6B | $1.7B | β$1.1B | $4.0B | $1.3B |
| Income tax | $266M | β$949M | $244M | $33.0M | β$76.0M | $865M | $367M | β$396M | $747M | $161M |
| Net income | $1.2B | $2.1B | $1.6B | $886M | $499M | $3.8B | $1.4B | β$752M | $3.3B | $1.2B |
| Net income to common | β | β | β | β | β | β | $1.4B | β$834M | $3.2B | $1.1B |
| Diluted EPS | $5.03 | $9.22 | $7.40 | $4.38 | $2.56 | $19.96 | $7.78 | β$4.92 | $18.41 | $5.83 |
| Diluted shares | 0.24B | 0.23B | 0.22B | 0.20B | 0.19B | 0.19B | 0.17B | 0.17B | 0.17B | 0.19B |
| Cash flow | ||||||||||
| Cash from operations | $1.3B | $788M | $1.9B | β$2.7B | $534M | β$217M | $3.6B | β$2.1B | β$2.0B | β$167M |
| Stock-based compensation | $46.0M | $50.0M | $52.0M | $62.0M | $51.0M | $61.0M | $51.0M | $61.0M | $64.0M | $78.0M |
| Acquisitions | β | β | $1.4B | β | β | β | β | β | β | β |
| Share buybacks | $879M | $725M | $900M | $550M | $275M | $1.1B | $550M | $0.0M | $0.0M | β |
| Dividends paid | $238M | $262M | $289M | $303M | $311M | $319M | $310M | $305M | $307M | $325M |
| Dividends and buybacks | $1.1B | $987M | $1.2B | $853M | $586M | $1.4B | $860M | $305M | $307M | $325M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $2.7B | $1.6B | $2.3B | $2.6B | $1.7B | $2.6B | $3.3B | $3.4B | $5.8B | $9.5B |
| Total debt | $5.1B | $5.6B | $5.7B | $6.4B | $6.3B | $6.6B | $6.8B | $5.9B | $6.2B | $6.3B |
| Finance lease liabilities | β | β | β | $281M | $234M | $175M | $106M | $27.0M | β | β |
| Loans, net | β | β | β | β | β | β | $18.3B | $19.0B | $21.1B | $22.5B |
| Goodwill | $2.3B | $1.4B | $1.8B | $1.8B | $1.8B | $1.8B | $1.1B | $1.1B | $1.1B | $1.1B |
| Total assets | $261.6B | $281.8B | $298.1B | $334.8B | $365.9B | $386.9B | $334.3B | $372.4B | $390.8B | $417.2B |
| Total liabilities | $247.1B | $264.4B | $283.8B | $315.1B | $343.2B | $366.2B | $329.2B | $365.5B | $382.6B | $406.3B |
| Shareholders' equity | $14.5B | $17.3B | $14.4B | $19.7B | $22.7B | $19.9B | $5.1B | $6.9B | $8.3B | $10.9B |
| Margins | ||||||||||
| Net margin | 8.9% | 14.6% | 10.0% | 5.1% | 2.9% | 21.3% | 7.2% | β6.5% | 17.8% | 6.5% |
| Returns | ||||||||||
| Return on equity | 8.2% | 13.1% | 10.4% | 5.2% | 2.4% | 17.7% | 10.9% | β12.5% | 43.2% | 12.3% |
| Return on assets | 0.5% | 0.8% | 0.6% | 0.3% | 0.1% | 1.0% | 0.4% | β0.2% | 0.9% | 0.3% |
| Return on tangible equity | 9.8% | 13.0% | 13.1% | 4.9% | 2.4% | 20.8% | 34.3% | β14.5% | 44.7% | 11.1% |
| Growth | ||||||||||
| Revenue growth | β | 7.0% | 15.2% | 5.1% | 1.0% | 1.6% | 6.2% | β38.1% | 58.4% | β1.2% |
| Net income growth | β | 74.4% | β21.1% | β46.0% | β43.7% | 657.1% | β64.1% | β155.4% | β | β64.1% |
| EPS growth | β | 83.3% | β19.7% | β40.8% | β41.6% | 679.7% | β61.0% | β163.2% | β | β68.3% |
| Share count change | β | β4.5% | β2.9% | β7.9% | β3.8% | β2.5% | β8.9% | β1.1% | 1.4% | 7.5% |
| Financial health | ||||||||||
| Debt / equity | 0.4x | 0.3x | 0.4x | 0.3x | 0.3x | 0.3x | 1.3x | 0.9x | 0.7x | 0.6x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 0.3% | 0.4% | 0.3% | 0.4% | 0.3% | 0.3% | 0.3% | 0.5% | 0.3% | 0.4% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 6.0 | 2.0 | 5.0 | 4.0 | 5.0 | 2.0 | 4.0 | 2.0 |
| Accruals ratio | β0.0% | 0.5% | β0.1% | 1.1% | β0.0% | 1.1% | β0.6% | 0.4% | 1.4% | 0.3% |
Source: SEC EDGAR XBRL filings (CIK 0000059558). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.